Pharmaceutical - Pharmaceutical, North America, Pricing

Filter

1 to 25 of 58 results

Patent lawyer seeking US Senate seat proposes patent reform to lower Rx drug costs

25-03-2014

Republican Art Gardner, a patent attorney seeking election to the US Senate in Georgia, has issued a…

North AmericaPatentsPharmaceuticalPoliticsPricingUSA

AHF sues Abbott and AbbVie for overcharging on AIDS drug pricing

AHF sues Abbott and AbbVie for overcharging on AIDS drug pricing

28-11-2013

In further legal action against drugmakers allegedly over pricing AIDS drugs in the USA, the AIDS Healthcare…

Abbott LaboratoriesAbbVieAnti-viralsKaletra TabletsLegalNorth AmericaNorvirPharmaceuticalPricing

AHF sues Johnson & Johnson over AIDS drug pricing

AHF sues Johnson & Johnson over AIDS drug pricing

01-11-2013

The Washington DC, USA-based AIDS Healthcare Foundation (AHF) has filed a law suit in the Superior Court…

Anti-viralsJanssenJohnson & JohnsonLegalNorth AmericaPharmaceuticalPricing

US infectious disease specialists’ prescribing choices for GNIs

US infectious disease specialists’ prescribing choices for GNIs

09-10-2013

A majority of US surveyed infectious disease specialists are willing to prescribe novel antibiotics if…

Antibiotics and Infectious diseasesMarkets & MarketingNorth AmericaPharmaceuticalPricing

US Senator seeks answers from drugmakers on providing required discounts

27-09-2013

US Senator Charles Grassley has written to two drug companies on behalf of an Iowa hospital that is not…

CSL BehringExparelHematologyKcentraNeurologicalNorth AmericaPacira PharmaceuticalsPharmaceuticalPoliticsPricing

AHF sues GSK for failing to provide discounts on HIV/AIDS drugs

11-09-2013

The USA-based AIDS Healthcare Foundation (AHF) said yesterday (September 10) that it has filed a law…

Anti-viralsGlaxoSmithKlineLegalNorth AmericaPharmaceuticalPricing

Bayer in settlement over Cipro pricing

04-09-2013

A partial settlement has been reached in a US class action law suit involving the prescription antibiotic…

Antibiotics and Infectious diseasesBayerCiproGenericsLegalNorth AmericaPharmaceuticalPricing

Mixed US views on Gilenya, Aubagio and Tecfidera as breakthrough MS drugs

03-09-2013

More than half of surveyed neurologists consider US biotech firm Biogen Idec's (Nasdaq: BIIB) Tecfidera…

AubagioBiogen IdecGilenyaMarkets & MarketingNeurologicalNorth AmericaNovartisPharmaceuticalPricingSanofiTecfidera

Health care reforms not keeping pace with needs of Canadians, says report

23-05-2013

The Health Council of Canada today (May 23) released Progress Report 2013: Health care renewal in Canada,…

HealthcareNorth AmericaPharmaceuticalPricing

US Senator Grassley questions continue about 340B discount drug program

09-05-2013

US Senator Chuck Grassley (Republican, Iowa) is looking into how hospitals are using a discount prescription…

North AmericaPharmaceuticalPoliticsPricing

Court rules in novel False Claims Act case where one pharma firm sues another viewed by HP&M lawyer

28-04-2013

The US District Court for the Central District of California issued a ruling recently in an unusual,…

AmphastarGenericsLegalLovenoxNorth AmericaPharmaceuticalPricingSanofi

High leukemia treatment costs may be harming patients, say experts

26-04-2013

The increasing cost of treatments for chronic myeloid leukemia (CML) in the USA has reached unsustainably…

North AmericaOncologyPharmaceuticalPricing

Legislation would undermine USA's Medicare Part D, argues PhRMA

18-04-2013

Several members of the US Congress this week echoed President Barack Obama's recycling of a "flawed policy…

HealthcareLegalNorth AmericaPharmaceuticalPricing

US Senator calls for re-examination of pricing of drugs developed with public funds

20-03-2013

US Senator Ron Wyden (Democrat, Oregon) has released a letter written to National Institutes of Health…

North AmericaPfizerPharmaceuticalPoliticsPricingResearchXeljanz

Independent US drugstore lobby wants sweeping Antitrust exemptions to charge higher prescription drug prices

18-03-2013

The independent drugstore lobby is again seeking special antitrust exemptions (HR 1188) that would empower…

LegalNorth AmericaPharmaceuticalPricing

Unnecessary drug regulations hiking Rx prices in USA: NCPA Study

08-03-2013

As drug coverage increases as a result of expanded health insurance and Medicaid coverage under the USA's…

BiotechnologyNorth AmericaPharmaceuticalPricingRegulation

Vivus announces new discount program for obesity drug Qsymia

06-03-2013

US drugmaker Vivus (Nasdaq: VVUS) has announced a new program offering eligible patients a discount on…

Markets & MarketingMetabolicsNorth AmericaPharmaceuticalPricingQsymiaVivus

US health care law allows consumers to easily find and compare options, says HHS Secretary

21-02-2013

US Department of Health and Human Services (HHS) Secretary Kathleen Sebelius yesterday announced a final…

FinancialHealthcareNorth AmericaPharmaceuticalPricing

Rise in drug costs to US hospitals and clinics slowing in 2013

18-02-2013

Although medicine costs will continue to rise in 2013 by as much as 4%, the increase is projected to…

Markets & MarketingNorth AmericaPharmaceuticalPricing

Study on generic HIV drugs prompts AHF to demand Gilead cuts ARV prices

16-01-2013

A new study published in the Annals of Internal Medicine that provides a snapshot of a simplified cost/benefit…

Anti-viralsAtriplaGenericsGilead SciencesNorth AmericaPharmaceuticalPricingStribild

US physician acquiescence to patient demands for brand-name drugs, slammed in JAMA article

09-01-2013

Prescribing brand-name drugs when generic drugs are available generates unnecessary medical expenditures…

FinancialGenericsHealthcareNorth AmericaPharmaceuticalPricing

Express Scripts finds most used Rx drugs price hikes six times that of overall US inflation

29-11-2012

The US Prescription Price Index shows that, since September 2011, price inflation for the most highly…

GenericsMarkets & MarketingNorth AmericaPharmaceuticalPricing

Survey reveals 98.9% of US physicians experienced cancer drug shortages in last 12 months

15-11-2012

The Community Oncology Alliance (COA), a US non-profit organization, announced the results of a drug…

GenericsHealthcareNorth AmericaOncologyPharmaceuticalPricing

Sanofi halves US price of Zaltrap, responding to criticism from oncologists

12-11-2012

French drug major Sanofi (Euronext: SAN) has said that it would halve the price of its colorectal cancer…

North AmericaOncologyPharmaceuticalPricingSanofiZaltrap

1 to 25 of 58 results

Back to top